Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
M THIS ANNOUNCEMENT (INCLUDING THE APPIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Therapeutics to Participate in Panel Sessions at the World...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Therapeutics Recognises C. difficile Awareness Month -- Company...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Therapeutics to Present at the 2019 BIO Investor Forum Oxford...
Summit Therapeutics PLC on Friday reported a first half loss as the company moved away from the development of ezutro ...
M Summit Therapeutics plc ('Summit' or the 'Company') Director Change Oxford, UK, and Cambridge, MA, US, 11 October 2019...
M Summit Therapeutics plc ('Summit', the 'Company' or the 'Group') Summit Therapeutics Reports Financial Results and...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Therapeutics to Report Financial Results for the Second Quarter...
Summit Therapeutics PLC on Monday presented new data explaining the result of its phase 2 ridinilazole antibiotic tri ...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Therapeutics Reports New Data from Phase 2 Clinical Trial...
Summit Therapeutics PLC on Thursday said results from the second phase of clinical trial of ridinilazole in C diffici ...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Therapeutics Reports Ridinilazole Significantly Improved Short...
M BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 3 October 2019 Name of...
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019 52 Presentations by Coalition Members During the Annual...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관